Why Basel Medical Group Ltd’s (BMGL) Stock Is Up 5.64%
As of Thursday, July 02, Basel Medical Group Ltd’s BMGL share price has surged by 5.64%, which has investors questioning if this is right time to sell.Michael Rose
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Jenna Brashear
Jenna Brashear
Jenna Brashear
Jenna Brashear
| Share Statistics | BMGL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $8.3 | $1,968.0 | 5% |
|
| Shares Out (Mil) | 1.2 | 77.7 | 5% |
|
| Institutional Ownership | 0.5% | 86.6% | 1% |
|
| Float (Mil) | 0.5 | 52.1 | 1% |
|
| Beta | na | 0.75 | na |
|
| Avg Daily Volume (000s) | 10 | 612 | 17% |
|
| Price Change (52-week) |
(76.9%) | 79.8% | 7% |
|
| Growth | BMGL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.9% | na |
|
| Net Income (5yr) | na | (1.6%) | na |
|
| EPS (5yr) | na | 0.3% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (17.9%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BMGL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $12 | $1,504 | 10% |
|
| Net Income (TTM) (Mil) | ($8) | $28 | 31% |
|
| EPS (TTM) | ($4.675) | $0.200 | 8% |
|
| Operating Cash Flow (TTM) (Mil) | ($2) | $162 | 30% |
|
| Net Cash Flow (TTM) (Mil) | ($5) | $9 | 34% |
|
| Long-Term Debt (Q1) (Mil) | $5 | $338 | 24% |
|
| Enterprise Value (Q1) (Mil) | $14 | $2,416 | 9% |
|
| Valuation | BMGL | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.70 | 2.82 | 44% |
|
| P/E | na | 26.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | BMGL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 14.0% | 27.8% | 13% |
|
| Net Margin | (68.2%) | 1.2% | 10% |
|
| ROA | (58.8%) | 2.2% | 10% |
|
| ROE | (153.2%) | 7.2% | 6% |
|
| Liabilities to Assets | 67.6% | 58.6% | 63% |
|
| F-Score | 3 | 5 | na |
|
Basel Medical Group Ltd did not pass any screens on 8/21/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors